publication venue for
- Patterns of Survivorship Follow-Up Care Among Patients With Breast Cancer: A Retrospective Population-Based Cohort Study in Ontario, Canada, Between 2006 and 2016. OP2300813. 2024
- Molecular Testing in Non–Small-Cell Lung Cancer: A Call to Action. 20:7-9. 2024
- Rates of surgery and adjuvant chemotherapy use in patients with stage IB to IIIA non-small cell lung cancer: A provincial population-based study.. 19:134-134. 2023
- Evaluating Oncology Clinical Pathways: What Bar Are We Aiming for?. 19:692-693. 2023
- Impact of Frailty on Health Care Resource Utilization and Costs of Care in Myelodysplastic Syndromes. 19:e559-e569. 2023
- Effect of Early Palliative Care on End-of-Life Health Care Costs: A Population-Based, Propensity Score–Matched Cohort Study. 18:e183-e192. 2022
- Prevalence and Workplace Drivers of Burnout in Cancer Care Physicians in Ontario, Canada. 18:e60-e71. 2022
- Development of Best Practices of Peer Review for Lung Radiation Therapy. 16:e1181-e1191. 2020
- Impact of Standardized Edmonton Symptom Assessment System Use on Emergency Department Visits and Hospitalization: Results of a Population-Based Retrospective Matched Cohort Analysis. 16:e958-e965. 2020
- Assessing the Impact of Early Identification of Patients Appropriate for Palliative Care on Resource Use and Costs in the Final Month of Life. 16:e688-e702. 2020
- Patterns of Ruxolitinib Therapy Failure and Its Management in Myelofibrosis: Perspectives of the Canadian Myeloproliferative Neoplasm Group. 16:351-359. 2020
- Examination of Health System Resources and Costs Associated With Transitioning Cancer Survivors to Primary Care: A Propensity-Score–Matched Cohort Study. 14:e653-e664. 2018
- Curative Stereotactic Ablative Radiotherapy for a Locally Advanced Basal Cell Carcinoma in an Elderly Patient. 14:389-391. 2018
- Case for Stopping Targeted Therapy When Lung Cancer Progresses on Treatment in Hospice-Eligible Patients. 13:780-783. 2017
- Has Province-Wide Symptom Screening Changed Opioid Prescribing Rates in Older Patients With Cancer?. 13:e927-e934. 2017
- American Society of Clinical Oncology Policy Brief: FDA’s Regulation of Electronic Nicotine Delivery Systems and Tobacco Products. 13:58-60. 2017
- Using Data From Ontario’s Episode-Based Funding Model to Assess Quality of Chemotherapy. 12:e870-e877. 2016
- Positron Emission Tomography–Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial. 12:e765-e774. 2016
- Quality Indicators of End-of-Life Care in Patients With Cancer: What Rate Is Right?. 11:e279-e287. 2015
- Supporting Models to Transition Breast Cancer Survivors to Primary Care: Formative Evaluation of a Cancer Care Ontario Initiative. 11:e288-e295. 2015
- Reasons for Delay in Time to Initiation of Adjuvant Chemotherapy for Colon Cancer. 11:e28-e35. 2015
- Creation of a Diagnostic Wait Times Measurement Framework Based on Evidence and Consensus. 10:e373-e379. 2014
- Cost-Effectiveness Analysis Comparing Conventional Versus Stereotactic Body Radiotherapy for Surgically Ineligible Stage I Non–Small-Cell Lung Cancer. 10:e130-e136. 2014
- International Efforts in Health Care Reform: Systemic Treatment Funding Model Reform in Ontario. 10:190-192. 2014
- Population-Based Standardized Symptom Screening: Cancer Care Ontario's Edmonton Symptom Assessment System and Performance Status Initiatives. 10:212-214. 2014
- Cost Effectiveness of a Survivorship Care Plan for Breast Cancer Survivors. 10:e86-e92. 2014
- Oncologists' Strategies and Barriers to Effective Communication About the End of Life. 9:e129-e135. 2013
- Use of Continuous Infusion Pumps During Radiation Treatment. 9:107-111. 2013
- Do High Symptom Scores Trigger Clinical Actions? An Audit After Implementing Electronic Symptom Screening. 8:e142-e148. 2012
- Technology Resource Planning in Radiation Oncology: Application of a Needs-Based Analytic Framework to Radiosurgery Planning in Ontario. 8:358-362. 2012
- Variation and Consternation: Access to Unfunded Cancer Drugs in Canada. 8:35-39. 2012
- Multidisciplinary Health Care Professionals' Perceptions of the Use and Utility of a Symptom Assessment System for Oncology Patients. 7:19-23. 2011
- Who Is Responsible? The Role of Family Physicians in the Provision of Supportive Cancer Care. 6:19-24. 2010
- Safe Handling of Parenteral Cytotoxics: Recommendations for Ontario. 5:245-249. 2009
- American Society of Clinical Oncology 2007 Clinical Practice Guideline Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer. 3:326-329. 2007
- Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline. 3:332-335. 2007